These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3546582)

  • 21. Increased Langerhans cell accumulation after mycobacterial stimuli.
    Miranda A; Amadeu TP; Schueler G; Alvarenga FB; Duppré N; Ferreira H; Nery JA; Sarno EN
    Histopathology; 2007 Nov; 51(5):649-56. PubMed ID: 17927586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
    Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
    N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme.
    Margolis RJ; Tonnesen MG; Harrist TJ; Bhan AK; Wintroub BU; Mihm MC; Soter NA
    J Invest Dermatol; 1983 Nov; 81(5):403-6. PubMed ID: 6631050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1-positive epidermal Langerhans cells in skin reactions to autologous peripheral-blood-derived mononuclear cells in leprosy patients.
    Narayanan RB; Natarajan M; Katoch K; Sengupta U
    Int Arch Allergy Appl Immunol; 1989; 89(1):38-42. PubMed ID: 2471696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in CD1 positive epidermal Langerhans cell numbers in leprosy lesions following epicutaneous application of 2:4 dinitrochlorobenzene.
    Narayanan RB; Natarajan M; Bagga AK; Katoch K
    Indian J Lepr; 1993; 65(4):423-7. PubMed ID: 8182289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular infiltrate in situ and response kinetics of human intradermal and epicutaneous tuberculin reactions.
    Konttinen YT; Bergroth V; Visa-Tolvanen K; Reitamo S; Förström L
    Clin Immunol Immunopathol; 1983 Sep; 28(3):441-9. PubMed ID: 6349886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of Langerhans cells in the epidermis of patients with leprosy.
    Gimenez MF; Gigli I; Tausk FA
    Br J Dermatol; 1989 Jul; 121(1):19-26. PubMed ID: 2757953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin.
    Siddiqui MR; Moreira AL; Negesse Y; Taye GA; Hanekom WA; Haslett PA; Britton S; Kaplan G
    J Infect Dis; 2002 Jul; 186(2):260-5. PubMed ID: 12134264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1 positive epidermal Langerhans cells in indeterminate leprosy.
    Narayanan RB; Natarajan M; Katoch K; Bagga AK
    Acta Leprol; 1988; 6(1):29-34. PubMed ID: 3051852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histiocytosis-X: in situ characterization of cutaneous infiltrates with monoclonal antibodies.
    Harrist TJ; Bhan AK; Murphy GF; Sato S; Berman RS; Gellis SE; Freedman S; Mihm MC
    Am J Clin Pathol; 1983 Mar; 79(3):294-300. PubMed ID: 6338698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermis-to-dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5.
    Ouwehand K; Scheper RJ; de Gruijl TD; Gibbs S
    Eur J Immunol; 2010 Jul; 40(7):2026-34. PubMed ID: 20432237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of cutaneous Langerhans cells of sarcoidosis patients.
    Fox JL; Berman B; Teirstein AS; France DS; Reed ML
    J Invest Dermatol; 1983 Jun; 80(6):472-5. PubMed ID: 6574191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parasitism of antigen presenting cells in hyperbacillary leprosy.
    Poulter LW; Collings LA; Tung KS; Waters MF
    Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis.
    Nilsen R; Mshana RN
    Scand J Immunol; 1987 Nov; 26(5):503-12. PubMed ID: 3120304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in situ immunohistological study of Mitsuda reactions.
    Dugan E; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):404-9. PubMed ID: 3900247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations of Langerhans' cells in leprosy using monoclonal antibody OKT6.
    Liu JH; Shi YF; Kong QY; Yang LH; Li WZ; Ye GY
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):524-6. PubMed ID: 6336044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.